| 7150 Mississauga Rd. | Phone: +1-905-286-3000 |
| Mississauga, ON | Fax: +1-905-286-3050 |
| L5N 8M5 | |
| Canada | 
Map This Company |
Valeant Pharmaceuticals International, Inc. Rankings
| TSX 60 |
Company Description
Valeant Pharmaceuticals (formerly Biovail) is a bold purveyor of neurological health. The drugmaker develops and sells central nervous system therapies, including Huntington's disease treatment Xenazine and Wellbutrin XL, an extended-release version of
Valeant Pharmaceuticals International, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Toronto: VRX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 4,300 |
Executives
23 executives listed for Valeant Pharmaceuticals International, Inc.'s Mississauga, ON location.
| Chairman and CEO | J. Michael Pearson | |
|---|---|---|
| EVP and COO | Gilbert Godin | |
| VP Technical Operations | John Sebben |